ZA991784B - Therapeutic treatment for renal dysfunction. - Google Patents

Therapeutic treatment for renal dysfunction.

Info

Publication number
ZA991784B
ZA991784B ZA9901784A ZA991784A ZA991784B ZA 991784 B ZA991784 B ZA 991784B ZA 9901784 A ZA9901784 A ZA 9901784A ZA 991784 A ZA991784 A ZA 991784A ZA 991784 B ZA991784 B ZA 991784B
Authority
ZA
South Africa
Prior art keywords
therapeutic treatment
renal dysfunction
dionehydrochloridesal
indoly1
buta
Prior art date
Application number
ZA9901784A
Other languages
English (en)
Inventor
Douglas Kirk Ways
Richard Gilbert
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA991784B publication Critical patent/ZA991784B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA9901784A 1998-03-05 1999-03-05 Therapeutic treatment for renal dysfunction. ZA991784B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7685298P 1998-03-05 1998-03-05

Publications (1)

Publication Number Publication Date
ZA991784B true ZA991784B (en) 1999-12-13

Family

ID=22134578

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9901784A ZA991784B (en) 1998-03-05 1999-03-05 Therapeutic treatment for renal dysfunction.

Country Status (10)

Country Link
US (1) US6225301B1 (de)
EP (1) EP0951903B1 (de)
JP (1) JP2002505278A (de)
AT (1) ATE360416T1 (de)
AU (1) AU2904799A (de)
CA (1) CA2323172A1 (de)
DE (1) DE69935881T2 (de)
ES (1) ES2285814T3 (de)
WO (1) WO1999044599A1 (de)
ZA (1) ZA991784B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050250725A1 (en) * 2000-06-16 2005-11-10 Price Peter M Regulation of the P21 gene and uses thereof
WO2007143119A2 (en) * 2006-06-01 2007-12-13 The Board Of Trustees Of The Leland Stanford Junior University Method of preventing progression of hypertension-induced heart failure with pkc peptides
EP2177510A1 (de) 2008-10-17 2010-04-21 Universität des Saarlandes Allosterische Proteinkinasemodulatoren

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227850A (en) 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
UA44690C2 (uk) 1993-12-07 2002-03-15 Елі Ліллі Енд Компані Макроциклічна сполука іміду біс-індол-малеїнової кислоти, спосіб її одержання та фармацевтична композиція, макроциклічні сполуки іміду біс-індол-малеїнової кислоти та біс-індол-малеїнового ангідриду, спосіб одержання (варіанти)
US5624949A (en) 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
JPH07238044A (ja) 1993-12-07 1995-09-12 Eli Lilly & Co ビスインドリルマレイミドの改良合成法
US5545636A (en) 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors
US5491242A (en) 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
US5481003A (en) 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
US5616577A (en) * 1994-08-25 1997-04-01 Smithkline Beecham Corporation Protein Kinase C inhibitor
US5559228A (en) 1995-03-30 1996-09-24 Eli Lilly And Company Synthesis of bisindolylmaleimides
EA000967B1 (ru) 1995-11-20 2000-08-28 Эли Лилли Энд Компани Ингибитор протеинкиназы c

Also Published As

Publication number Publication date
AU2904799A (en) 1999-09-20
EP0951903A1 (de) 1999-10-27
WO1999044599A1 (en) 1999-09-10
ATE360416T1 (de) 2007-05-15
EP0951903B1 (de) 2007-04-25
JP2002505278A (ja) 2002-02-19
DE69935881D1 (de) 2007-06-06
ES2285814T3 (es) 2007-11-16
DE69935881T2 (de) 2008-01-10
CA2323172A1 (en) 1999-09-10
US6225301B1 (en) 2001-05-01

Similar Documents

Publication Publication Date Title
FR10C0041I2 (de)
CA2253613A1 (en) Therapeutic treatment for vegf related occular diseases
IL127524A0 (en) Therapeutic treatment for cardiovascular diseases
ZA991784B (en) Therapeutic treatment for renal dysfunction.
AU4157597A (en) Therapeutic treatment for sexual dysfunctions
EP0410794A3 (en) Maleimide containing, negative working deep uv photoresist
EP0940141A3 (de) Verwendung von PKC-Inhibitoren zur Herstellung eines Arzneimittels zur Behandlung von Cytomegalovirusinfektionen
AU5410696A (en) Chain saw guide bar
ZA984825B (en) A nes therapeutic use for glycine
EP0940143A3 (de) Verwendung von PKC-Inhibitoren zur Herstellung eines Arzneimittels zur Behandlung von Asthma
ZA971217B (en) Diamond treatment.
SI1196172T1 (sl) (S,S)-reboksetin za zdravljenje kronicne bolecine
ES2141044A1 (es) Terapia con oxibutinina.
IT234986Y1 (it) Zavorra, in particolare per l'uso in attivita' subaquee
GB9804349D0 (en) Qur'anic therapy
ITBS950009A0 (it) Una leva individuale mobile per biciclette
UA36385A (uk) Спосіб лікування генералізованого пародонтиту
IT1288676B1 (it) Dispositivo di aerazione, particolarmente per pattini
ZA966129B (en) Treatment of attention-deficit/hyperactivity disorder.